Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries
Fewer than half of the world's infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.
Authors
- Su H Wang
- Oliver Ezechi (ORCID: https://orcid.org/0000-0003-0688-3898)
- Peyton Thompson (ORCID: https://orcid.org/0000-0002-9679-9763)
- Jonathan B. Parr (ORCID: https://orcid.org/0000-0002-4465-9830)
- Devin Razavi‐Shearer (ORCID: https://orcid.org/0000-0003-4135-1053)
- Joseph D. Tucker (ORCID: https://orcid.org/0000-0003-2804-1181)
- Alix Boisson
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2025-03-27
- DOI
- https://doi.org/10.17615/d1vn-hs96
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00